The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population (Q33792732)

29 July 2017

title

The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population (English)

1 reference

ORCID Public Data File 2021

29 July 2017

1 reference

author name string

Vida Stegel

1

1 reference

29 July 2017

Mateja Krajc

2

1 reference

29 July 2017

Janez Zgajnar

3

1 reference

29 July 2017

Erik Teugels

4

1 reference

29 July 2017

Jacques De Grève

5

1 reference

29 July 2017

Marko Hočevar

6

1 reference

29 July 2017

Srdjan Novaković

7

1 reference

29 July 2017

publication date

14 January 2011

1 reference

29 July 2017

1 reference

29 July 2017

volume

12

1 reference

29 July 2017

page(s)

9

1 reference

Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

The contribution of BRCA1 and BRCA2 to ovarian cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Hereditary breast cancer: from bench to bedside.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in north-east of Italy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Characterization of BRCA1 and BRCA2 mutations in a large United States sample

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

BRCA2 founder mutation in Slovenian breast cancer families.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

BRCA1 and BRCA2 mutations in central and southern Italian patients.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Identification of the breast cancer susceptibility gene BRCA2

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Genetic analysis of breast cancer in the cancer and steroid hormone study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

4 July 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2350-12-9

Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2350-12-9

Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2350-12-9

Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2350-12-9

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2350-12-9

Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2350-12-9

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2350-12-9

BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2350-12-9

Breast cancer susceptibility variants alter risk in familial ovarian cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3025939

Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family

30 October 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2350-12-9

BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central Italy

21 January 2018

1 reference

12 December 2020

BRCA2 germline mutations in male breast cancer cases and breast cancer families

1 reference

12 December 2020

BRCA1 andBRCA2 genes: Role in hereditary breast and ovarian cancer in Italy

1 reference

12 December 2020

BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models

1 reference

12 December 2020

Contribution ofBRCA1andBRCA2mutations to inherited ovarian cancer

1 reference

12 December 2020

BRCA2 gene mutations in Slovenian male breast cancer patients

1 reference

12 December 2020

Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families

1 reference

12 December 2020

Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2350-12-9

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference